Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-GEOD-67338

ABSTRACT: Expression data of human neuroblastoma IMR32 cells treated with the DHODH inhibitor Teriflunomide [118 ï¿‚ï¾µM]

PROVIDER: E-GEOD-67338 | ExpressionAtlas | 2025-01-24

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-GEOD-67338-analysis-methods.tsv	Tabular
	E-GEOD-67338-atlasExperimentSummary.Rdata	Rdata
	E-GEOD-67338-configuration.xml	Xml
	E-GEOD-67338-percentile-ranks.tsv	Tabular
	E-GEOD-67338.condensed-sdrf.tsv	Tabular

Items per page:

1 - 5 of 53

Similar Datasets

Homo sapiens

Project description:Expression data of human neuroblastoma IMR32 cells treated with the DHODH inhibitor Teriflunomide [118 µM]

| PRJNA279535 | ENA

Transcription profiling of human neuroblastoma samples to identify candidate genes by combining genomic and expression microarrays. Super series see E-GEOD-13136 and E-GEOD-13137

Project description:This SuperSeries is composed of the following subset Series:; GSE13136: Identification of candidate neuroblastoma genes by combining genomic and expression microarrays: expression data; GSE13137: Identification of candidate neuroblastoma genes by combining genomic and expression microarrays: SNP data Experiment Overall Design: Refer to individual Series

2008-10-26 | E-GEOD-13141 | biostudies-arrayexpress

Homo sapiens

Project description:Expression data of human neuroblastoma SK-N-AS treated with the PLK1 inhibitor GSK461364

| PRJNA278960 | ENA

Destabilization of the noncanonical PRC1.1 complex via USP7 inhibition induces neuronal differentiation in neuroblastoma

Project description:Proteomics and ubiquitinomics datasets from neuroblastoma cells treated with the USP7 inhibitor XL177A.

| MSV000099123 | MassIVE

Alteration of treatment of the ALK inhibitor in ALK-amplified neuroblastoma

Project description:Anaplastic Lymphoma Kinase (ALK) most frequently mutated in neuroblastoma (NB) and is atractive molecular target for therapy. However, efficacy of the ALK inhibitor against ALK-amplified NB is unclear. To elucidate genetic alterations induced by treatment of the ALK inhibitor, we compared expression profile between ALK inhibitor-treated and DMSO-treated NB39nu cells using Agilent SurePrint G3 Human GE 8x60K V2 Microarray Kit

2017-11-28 | GSE107354 | GEO

Expression data from SH-SY5Y neuroblastoma cells treated with the protein disulfide isomerase inhibitor origamicin

Project description:Expression data from SH-SY5Y neuroblastoma cells treated with the protein disulfide isomerase inhibitor origamicin

| PRJNA530280 | ENA

Human Differentiated SH-SY5Y neuroblastoma cells treated with Granzyme K

Project description:Human Differentiated SH-SY5Y neuroblastoma cells treated with 150 nM GrK alone or together with 100 nM SCH79797 PAR-1 inhibitor to evaluate the impact of granzyme K (GrK) on neuronal functions.

2025-06-24 | PXD064640 | Pride

CAMKV inhibitor, OTSSP167 induces transcriptomic changes in NGP cells

Project description:To investigate the effect of CAMKV inhibitor, OTSSP167, on NB cell proliferation and delineate the mechanisms of CAMKV-mediated pathway inhibition in NB. We treated human neuroblastoma cell line, NGP with OTSSP167 and performed gene expression profiling analysis using data obtained from RNA-seq.

2024-10-24 | GSE255692 | GEO

ERK inhibitor, ulixertinib induces transcriptomic changes in NGP cells

Project description:To investigate the effect of ERK inhibitor, ulixertinib, on NB cell proliferation and delineate the mechanisms of ulixertinib-mediated ERK pathway inhibition in NB. We treated human neuroblastoma cell line, NGP with ulixertinib and performed gene expression profiling analysis using data obtained from RNA-seq.

2023-03-01 | GSE213153 | GEO

Expression data from neuroblastoma cells treated with MI-773

Project description:Expression data from neuroblastoma cells treated with MI-773

| PRJNA729997 | ENA